Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep;35(9):1587-1596.
doi: 10.1007/s10554-019-01597-7. Epub 2019 Apr 16.

Left atrial longitudinal strain by speckle tracking as independent predictor of recurrence after electrical cardioversion in persistent and long standing persistent non-valvular atrial fibrillation

Affiliations

Left atrial longitudinal strain by speckle tracking as independent predictor of recurrence after electrical cardioversion in persistent and long standing persistent non-valvular atrial fibrillation

Luis Antonio Moreno-Ruiz et al. Int J Cardiovasc Imaging. 2019 Sep.

Abstract

Atrial fibrillation (AF) is the most common arrhythmia in humans. After successful cardioversion, there is a recurrence of 60% due to atrial remodeling, and it has been shown that the global peak atrial longitudinal strain (GPALS) is decreased in these subjects. The aim of this study was to evaluate the predictive value of GPALS for AF recurrence. A prospective cohort of patients with persistent (PnVAF) and long standing persistent non-valvular AF (LSPnVAF) which underwent electrical cardioversion was evaluated with standard echocardiographic variables and GPALS quantification. The primary endpoint was AF recurrence at 6 months. We included PnVAF (n = 50, aged 68.4 ± 10.2 years, female 46%, lasted AF 6 months) and LSPnVAF (n = 81, aged 66.5 ± 13.1 years, female 36%, lasted AF 18 months). At 6 months there were a 68% of recurrence of AF in PnVAF and 53% in LSPnVAF group. GPALS was lower in recurrence 7.8 ± 2.0% versus 21.2 ± 8.9% (p < 0.001) for PnVAF and 7.3 ± 2.7% versus 20.7 ± 7.6% (p < 0.001) in LSPnVAF. GPALS ≤ 10.75% discriminates recurrence at 6 months with a sensitivity of 85%, specificity 99%, PPV 85%, NPV 90%, LR + 8.5 and LR- 0.17. The independent predictors of recurrence in PnVAF were GPALS ≤ 10.75% HR 8.89 [(2.2-35.7), p < 0.01] meanwhile in LSPnVAF were age HR 1.039 [(1.007-1.071), p = 0.01], and GPALS ≤ 10.75% HR 28.1 [(7.2-109.1), p < 0.001]. In subjects with PnVAF and LSPnVAF with successful electrical cardioversion, GPALS ≤ 10.75% predicts arrhythmia recurrence at 6-month follow-up.

Keywords: Atrial fibrillation; Longitudinal atrial strain; Recurrence.

PubMed Disclaimer

Conflict of interest statement

All authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Representative global peak atrial longitudinal strain (GPALS) images. Apical long axes of four (a) and two chambers (b) with tracing the atrial endocardial border. Automated GPALS quantification with two-dimensional speckle tracking in apical views of four (c) and two chambers (d). We defined GPALS as the average of three beats each, in this case GPALS was 6.8% in a subject with AF recurrence. GPALS global peak atrial longitudinal strain, AF atrial fibrillation
Fig. 2
Fig. 2
Atrial deformation according to the presence or absence of recurrence after cardioversion, GPALS is lower in subjects with recurrence versus subjects who remained in sinus rhythm in both groups of AF. *U Mann–Whitney. GPALS global peak atrial longitudinal strain, PnVAF persistent non-valvular AF, LSPnVAF long standing persistent non-valvular AF
Fig. 3
Fig. 3
ROC curve for GPALS and risk of recurrence after cardioversion in subjects with PnVAF and LSPnVAF. A cut-point of GPALS ≤ 10.75% identifies recurrence with S 85%, E 99%, PPV 85%, NPV 90%, LR+ 8.5 and LR− 0.17. GPALS global peak atrial longitudinal strain, PnVAF persistent non-valvular AF, LSPnVAF long standing persistent non-valvular AF, PPV positive predictive value, NPV negative predictive value, LR+ positive likelihood ratio, LR− negative likelihood ratio
Fig. 4
Fig. 4
Recurrence-free survival curve of subjects with PnVAF (a) and LSPnVAF (b) according to the GPALS cut-point obtained by Youden index. The subjects with GPALS ≤ 10.75% have greater recurrence at 6 months versus subjects with GPALS ≥ 10.76%. PnVAF persistent non-valvular AF, LSPnVAF long standing persistent non-valvular AF, GPALS global peak atrial longitudinal strain

References

    1. Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, Van Gelder I, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Afieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH, ESC Committee for Practice Guidelines Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J. 2010;31:2369–2429. doi: 10.1093/eurheartj/ehq278. - DOI - PubMed
    1. Khaykin Y, Shamiss Y. Costs considerations in the management of atrial fibrillation—impact of dronedarone. Clinicoecon Outcomes Res. 2012;4:67–68. doi: 10.2147/CEOR.S16675. - DOI - PMC - PubMed
    1. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001;104:2517–2524. doi: 10.1161/hc4601.097997. - DOI - PubMed
    1. Wolf PA, Mitchell JB, Baker CS, Kannel WB, D’Agostino RB. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med. 1998;158:229–234. doi: 10.1001/archinte.158.3.229. - DOI - PubMed
    1. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946–952. doi: 10.1161/01.CIR.98.10.946. - DOI - PubMed

MeSH terms